Oppenheimer raised the firm’s price target on Nasdaq to $84 from $80 and keeps an Outperform rating on the shares. As the company transforms into a technology provider, which drives higher organic growth and recurring revenue, the firm believes it can support both stable earnings growth and re-rating. A potential IPO recovery in 2025 is another catalyst to drive multiple expansion, Oppenheimer adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDAQ:
- Nasdaq upgraded to Outperform from Market Perform at Raymond James
- The Week That Was, The Week Ahead: Macro & Markets, October 13, 2024
- 3 Economic Events That Could Affect Your Portfolio This Week, October 14–18, 2024
- Nasdaq price target raised to $80 from $73 at Piper Sandler
- Nasdaq price target raised to $84 from $77 at Barclays
